Lilly builds Suzhou plant
Print Edition
ELI Lilly & Co started building its third manufacturing plant in Suzhou, Jiangsu Province, yesterday, with the United States pharmaceutical giant saying it will continue a robust investment pace in China although it is downsizing its footprint in other regions.
Located in the Suzhou Industrial Park, the project involves a total investment of 2 billion yuan (US$322 million), about three times the total that Lilly has invested in Suzhou.
“The new project is an evidence that we are going to continue to invest in China in a very robust way even though we’re facing difficulties in other markets,” said John C. Lechleiter, chief executive officer of Lilly.
The Indianapolis-based firm has been making cutbacks in the US and Europe as it deals with the loss of patent protection for some of its top drugs.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
